Enhancing the abscopal effect of radiation and immune checkpoint inhibitor therapies with magnetic nanoparticle hyperthermia in a model of metastatic breast cancer

References

• Carey LA, Perou CM, Livasy CA. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA. 2006;295(21):2492–2502.
   PubMed Web of Science ®Google Scholar
• Anders C, Carey LA. Understanding and treating triple-negative breast cancer. Oncology. 2008;22(11):1233–1239. discussion 1239-1240,1243.
   PubMed Web of Science ®Google Scholar
• Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res. 2007;13(15):4429–4434.
   PubMed Web of Science ®Google Scholar
• Kassam F, Enright K, Dent R, et al. Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design. Clin Breast Cancer. 2009;9(1):29–33.
   PubMed Web of Science ®Google Scholar
• Chen MT, Sun HF, Zhao Y, et al. Comparison of patterns and prognosis among distant metastatic breast cancer patients by age groups: a SEER population-based analysis. Sci Rep. 2017;7(1):9254.
   PubMed Web of Science ®Google Scholar
• Tseng LM, Hsu NC, Chen SC, et al. Distant metastasis in triple-negative breast cancer. Neoplasma. 2013;60(03):290–294.
   PubMed Web of Science ®Google Scholar
• Willett WC. Epidemiology and nongenetic causes of breast cancer. In: Harris JR, Lippman ME, Morrow M, Osborn CK, editors. Diseases of the breast. Philadelphia, PA: Lippincott Williams & Wilkins; 2000. p. 175.
   Google Scholar
• Refaat T, Sachdev S, Sathiaseelan V, et al. Hyperthermia and radiation therapy for locally advanced or recurrent breast cancer. Breast. 2015;24(4):418–425.
   PubMed Web of Science ®Google Scholar
• Oldenborg S, Van Os RM, Van Rij CM, et al. Elective re-irradiation and hyperthermia following resection of persistent locoregional recurrent breast cancer: a retrospective study. Int J Hyperthermia. 2010;26(2):136–144.
   PubMed Web of Science ®Google Scholar
• Linthorst M, Baaijens M, Wiggenraad R, et al. Local control rate after the combination of re-irradiation and hyperthermia for irresectable recurrent breast cancer: results in 248 patients. Radiother Oncol. 2015;117(2):217–222.
   PubMed Web of Science ®Google Scholar
• Bianchini G, Gianni L. The immune system and response to HER2-targeted treatment in breast cancer. Lancet Oncol. 2014;15:e45–e68.
   Web of Science ®Google Scholar
• Drake CG. Combination immunotherapy approaches. Ann Oncol. 2012;23(Suppl 8):viii41–viii46.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674.
   PubMed Web of Science ®Google Scholar
• Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science. 2011;331(6024):1565–1570.
   PubMed Web of Science ®Google Scholar
• Koebel CM, Vermi W, Swann JB, et al. Adaptive immunity maintains occult cancer in an equilibrium state. Nature. 2007;450(7171):903–907.
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Apetoh L, Ghiringhelli F, et al. The anticancer immune response: indispensable for therapeutic success? J Clin Invest. 2008;118(6):1991–2001.
   PubMed Web of Science ®Google Scholar
• Dewan ZM, Galloway AE, Kawashima N, et al. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin Cancer Res. 2009;15(17):5379–5388.
   PubMed Web of Science ®Google Scholar
• Demaria S, Kawashima N, Yang AM, et al. Immune-mediated inhibition of metastases after treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res. 2015;11:728–734.
   Google Scholar
• Shu CA, Rizvi NA. Into the clinic with nivolumab and pembrolizumab. Oncologist. 2016;21(5):527–528.
   PubMed Web of Science ®Google Scholar
• Hodi FS, O'Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med. 2010;363(8):711–723.
   PubMed Web of Science ®Google Scholar
• Wolchok JD, Kluger H, Callahan MK, et al. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2013;369(2):122–133.
   PubMed Web of Science ®Google Scholar
• Callahan MK, Postow MA, Wolchok JP. CTLA-4 and PD-1 pathway blockade: combinations in the clinic. Front Oncol. 2014;4:385.
   PubMed Web of Science ®Google Scholar
• Hassel JC, Heinzerling L, Aberle J, et al. Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): evaluation and management of adverse drug reactions. Cancer Treat Rev. 2017;57:36–49.
   PubMed Web of Science ®Google Scholar
• Mole RH. Whole body irradiation; radiobiology or medicine? BJR. 1953;26(305):234–241.
   Google Scholar
• Verbrugge I, Hagekyriakou J, Sharp LL, et al. Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies. Cancer Res. 2012;72(13):3163–3174.
   PubMed Web of Science ®Google Scholar
• Postow MA, Callahan MK, Barker CA, et al. Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med. 2012;366(10):925–931.
   PubMed Web of Science ®Google Scholar
• Hodge JW, Sharp HJ, Gameiro SR. Abscopal regression of antigen disparate tumors by antigen cascade after systemic tumor vaccination in combination with local tumor radiation. Cancer Bioth Radiopharm. 2012;27:12–22.
   PubMed Web of Science ®Google Scholar
• Hu ZI, McArthur HL, Ho AY. The abscopal effect of radiation therapy: what is it and how can we use it in breast cancer? Curr Breast Cancer Rep. 2017;9(1):45–51.
   PubMed Web of Science ®Google Scholar
• Wang HY, Fu JC, Lee YC, et al. Hyperthermia stress activates heat shock protein expression via propyl isomerase 1 regulation with heat shock factor 1. Mol Cell Biol. 2013;33(24):4889–4899.
   PubMed Web of Science ®Google Scholar
• Basu S, Binder RJ, Suto R, et al. Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway. Int Immunol. 2000;12(11):1539–1546.
   PubMed Web of Science ®Google Scholar
• Sauter B, Albert ML, Francisco L, et al. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J Exp Med. 2000;191(3):423–434.
   PubMed Web of Science ®Google Scholar
• Repasky EA, Evans SS, Dewhirst MW. Temperature matters! And why it should matter to tumor immunologists. Cancer Immunol Res. 2013;1(4):210–216.
   PubMed Web of Science ®Google Scholar
• Knippertz I, Stein MF, Dorrie J, et al. Mild hyperthermia enhances human monocyte-derived dendritic cell functions and offers potential for applications in vaccination strategies. Int J Hyperthermia. 2011;27(6):591–603.
   PubMed Web of Science ®Google Scholar
• Frey B, Weiss EM, Rubner Y, et al. Old and new facts about hyperthermia-induced modulations of the immune system. Int J Hyperthermia. 2012;28(6):528–542.
   PubMed Web of Science ®Google Scholar
• Mace TA, Zhong L, Kokolus KM, et al. Effector CD8+ T-cell IFN-γ production and cytotoxicity are enhance by mild hyperthermia. Int J Hyperthermia. 2012;28(1):9–18.
   PubMed Web of Science ®Google Scholar
• Hatzfeld-Charbonnier AS, Lasek A, Castera L, et al. Influence of heat stress on human monocyte-derived dendritic cell functions with immunotherapeutic potential for antitumor vaccines. J Leukocyte Biol. 2007;81(5):1179–1187.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Bernstein MB, Hodge JW. Enhancing immune responses to tumor-associated antigens. Cancer Biol Ther. 2009;8(15):1440–1449.
   PubMed Web of Science ®Google Scholar
• Dewhirst MW, Jones E, Samulski T. Hyperthermia. Cancer medicine. 6th ed. Hamilton: BC Decker; 2003. p. 623–636.
   Google Scholar
• Horsman MR, Overgaard J. Hyperthermia: a potent enhancer of radiation. Clin Oncol. 2007;19(6):418–426.
   PubMed Web of Science ®Google Scholar
• Krawczyk PM, Eppink B, Essers J, et al. Mild hyperthermia inhibits homologous recombination, induces BRCA2 degradation, and sensitizes cancer cells to poly (ADP-ribose) polymerase-1 inhibition. Proc Natl Acad Sci. 2011;108(24):9851–9856.
   PubMed Web of Science ®Google Scholar
• Bergs JWJ, Krawczyk PM, Borovski T, et al. Inhibition of homologous recombination by hyperthermia shunts early double strand break repair to non-homologous end-joining. DNA Repair. 2013;12(1):38–45.
   PubMed Web of Science ®Google Scholar
• Tuul M, Kitao H, Iimori M, et al. Rad9, Rad17, TopBP1 and Claspin play essential roles in heat-induced activation of ATR kinase and heat tolerance. PLoS ONE. 2013;8(2):e55361.
   PubMed Web of Science ®Google Scholar
• Pankhurst QA, Thanh NKT, Jones SK, et al. Progress in applications of magnetic nanoparticles in biomedicine. J Phys D Appl Phys. 2009;42(22):224001–224016.
   Web of Science ®Google Scholar
• Ivkov R. Magnetic nanoparticle hyperthermia: a new frontier in biology and medicine? Int J Hyperthermia. 2013;29(8):703–705.
   PubMed Web of Science ®Google Scholar
• Dennis CL, Ivkov R. Physics of heat generation using magnetic nanoparticles for hyperthermia. Int J Hyperthermia. 2013;29(8):715–729.
   PubMed Web of Science ®Google Scholar
• Johannsen M, Gneveckow U, Eckelt L, et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles: presentation of a new interstitial technique. Int J Hyperthermia. 2005;21(7):637–647.
   PubMed Web of Science ®Google Scholar
• Maier-Hauff K, Ulrich F, Nestler D, et al. Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme. J Neurooncol. 2011;103(2):317–324.
   PubMed Web of Science ®Google Scholar
• Dennis CL, Jackson AJ, Borchers JA, et al. Nearly complete regression of tumors via collective behavior of magnetic nanoparticles in hyperthermia. Nanotechnology. 2009;20(39):395103.
   PubMed Web of Science ®Google Scholar
• Zadnik P, Molina C, Sarabia-Estrada R, et al. Characterization of intra-tumor magnetic nanoparticle distribution and heating in a rat model of metastatic spine disease. J Neurosurg Spine. 2014;20(6):740–750.
   PubMed Web of Science ®Google Scholar
• Guistini AJ, Ivkov R, Hoopes PJ. Magnetic nanoparticle biodistribution following intratumoral administration. Nanotechnology. 2001;22:345101.
   Web of Science ®Google Scholar
• DeNardo SJ, DeNardo GL, Miers LA, et al. Development of tumor targeting bioprobes (111In-chimeric L6 monoclonal antibody nanoparticles) for alternating magnetic field cancer therapy. Clin Cancer Res. 2005;11(19):7087s–7092s.
   PubMed Web of Science ®Google Scholar
• DeNardo SJ, DeNardo GL, Natarajan A, et al. Thermal dosimetry predictive of efficacy of 111In-Ch L6 nanoparticle AMF induced therapy for human breast cancer in mice. J Nucl Med. 2007;48(3):437–444.
   PubMed Web of Science ®Google Scholar
• Attaluri A, Kandala SK, Zhou H, et al. Magnetic nanoparticle hyperthermia enhances radiation therapy: a study in mouse models of human prostate cancer. Int J Hyperthermia. 2015;31(4):359–374.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang JJ, Huang XY. Mouse models for tumor metastasis. Methods Mol Biol. 2012;928:221–228.
   PubMedGoogle Scholar
• Gruettner C, Mueller K, Teller J, et al. Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J Magn Magn Mater. 2007;311:181–186.
   Web of Science ®Google Scholar
• Natarajan A, Gruettner C, Ivkov R, et al. NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics. Bioconjugate Chem. 2008;19(6):1211–1218.
   PubMed Web of Science ®Google Scholar
• Sharma A, Cornejo Mihalic J, et al. Physical characterization and in vivo organ distribution of coated iron oxide nanoparticles. Sci Rep. 2018;20:4916.
   Web of Science ®Google Scholar
• Dennis CL, Krycka KL, Borchers JA, et al. Internal magnetic structure of nanoparticles dominates time-dependent relaxation processes in a magnetic field. Adv Funct Mater. 2015;25(27):4300–4311.
   Web of Science ®Google Scholar
• Bordelon DE, Cornejo C, Grüttner C, et al. Magnetic nanoparticle heating efficiency reveals magneto-structural differences when characterized with wide ranging and high amplitude alternating magnetic fields. J Appl Phys. 2011;109(12):124904.
   Web of Science ®Google Scholar
• Bordelon DE, Goldstein RC, Nemkov VS, et al. Modified solenoid coil that efficiently produces high amplitude AC magnetic fields with enhanced uniformity for biomedical applications. IEEE Trans Magn. 2012;48(1):47–52.
   Web of Science ®Google Scholar
• Kumar A, Attaluri A, Mallipudi R, et al. Method to reduce non-specific heating of small animals in solenoid coils. Int J Hyperthermia. 2013;29(2):106–120.
   PubMed Web of Science ®Google Scholar
• Wong J, Armour E, Kazanzides P, et al. High-resolution, small animal radiation research platform with X-ray tomographic guidance capabilities. Int J Radiat Oncol. 2008;71(5):1591–1599.
   PubMed Web of Science ®Google Scholar
• Gilchrist RK, Medal R, Shorey WD, et al. Selective inductive heating of lymph nodes. Ann Surgery. 1957;146(4):596–606.
   PubMed Web of Science ®Google Scholar
• Kandala SK, Liapi E, Whitcomb LL, et al. Temperature-controlled power modulation compensates for heterogeneous nanoparticle distributions: a computational optimization analysis for magnetic hyperthermia. Int J Hyperthermia. 2019;36(1):115–129.
   PubMed Web of Science ®Google Scholar
• Kim K, Skora AD, Li Z, et al. Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells. Proc Natl Acad Sci. 2014;111(32):11774–11779.
   PubMed Web of Science ®Google Scholar
• Prosnitz LR, Maguire P, Anderson JM, et al. The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. Int J Radiat Oncol Biol Phys. 1999;45(4):941–949.
   PubMed Web of Science ®Google Scholar
• Lewis JJ, Leung D, Heslin M, et al. Association of local recurrence with subsequent survival in extremity soft tissue sarcoma. JCO. 1997;15(2):646–652.
   PubMed Web of Science ®Google Scholar
• Gustafson P, Rooser B, Rydholm A. Is local recurrence of minor importance for metastases in soft tissue sarcoma? Cancer. 1991;67(8):2083–2086.
   PubMed Web of Science ®Google Scholar
• Hill SA, Denekamp J. Does local tumour heating in mice influence metastatic spread? BJR. 1982;55(654):444–451.
   Google Scholar
• Oda M, Koga S, Maeta M. Effects of total-body hyperthermia on metastases from experimental mouse tumors. Cancer Res. 1985;45:1532–1535.
   PubMed Web of Science ®Google Scholar
• Urano J, Rice L, Epstein R, et al. Effect of whole-body hyperthermia on cell survival, metastasis frequency and host immunity in moderately and weakly immunogenic murine tumors. Cancer Res. 1983;43(3):1039–1043.
   PubMed Web of Science ®Google Scholar
• Yerushalmi A. Influence on metastatic spread of whole-body or local tumor hyperthermia. Eur J Cancer. 1976;12(6):455–463.
   PubMed Web of Science ®Google Scholar
• Thrall DE, Prescott DM, Samulski TV, et al. Radiation plus local hyperthermia versus radiation plus the combination of local and whole-body hyperthermia in canine sarcomas. Int J Radiat Oncol Biol Phys. 1996;34(5):1087–1096.
   PubMed Web of Science ®Google Scholar
• Vasanthan A, Mitsumori M, Park JH, et al. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency. Int J Radiat Oncol Biol Phys. 2005;61(1):145–153.
   PubMed Web of Science ®Google Scholar
• Franckena M, Stalpers LJ, Koper PC, et al. Long-term improvement in the treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial. Int J Radiat Oncol Biol Phys. 2008;70(4):1176–1182.
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Sheen MR, Zhang P, et al. Local hyperthermia treatment of tumors induces CD8+ T cell-mediated resistance against distal and secondary tumors. Nanomedicine. 2014;10(6):1273–1285.
   PubMed Web of Science ®Google Scholar
• Hoopes PJ, Wagner RJ, Song A, et al. The effect of hypofractionated radiation and magnetic nanoparticle hyperthermia on tumor immunogenicity and overall treatment response. Proc SPIE Int Soc Opt Eng. 2017;10066:100660D1–100660D22.
   Google Scholar
• Wang H, Zhang L, Shi Y, et al. Abscopal antitumor immune effects of magnet-mediated hyperthermia at a high therapeutic temperature on Walker-256 carcinosarcomas in rats. Oncol Lett. 2014;7(3):764–770.
   PubMed Web of Science ®Google Scholar